Correlation Between Smith Nephew and Fresenius Medical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Smith Nephew and Fresenius Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Smith Nephew and Fresenius Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Smith Nephew SNATS and Fresenius Medical Care, you can compare the effects of market volatilities on Smith Nephew and Fresenius Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Smith Nephew with a short position of Fresenius Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Smith Nephew and Fresenius Medical.

Diversification Opportunities for Smith Nephew and Fresenius Medical

-0.49
  Correlation Coefficient

Very good diversification

The 3 months correlation between Smith and Fresenius is -0.49. Overlapping area represents the amount of risk that can be diversified away by holding Smith Nephew SNATS and Fresenius Medical Care in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fresenius Medical Care and Smith Nephew is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Smith Nephew SNATS are associated (or correlated) with Fresenius Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fresenius Medical Care has no effect on the direction of Smith Nephew i.e., Smith Nephew and Fresenius Medical go up and down completely randomly.

Pair Corralation between Smith Nephew and Fresenius Medical

Considering the 90-day investment horizon Smith Nephew is expected to generate 8.92 times less return on investment than Fresenius Medical. But when comparing it to its historical volatility, Smith Nephew SNATS is 1.22 times less risky than Fresenius Medical. It trades about 0.06 of its potential returns per unit of risk. Fresenius Medical Care is currently generating about 0.41 of returns per unit of risk over similar time horizon. If you would invest  2,005  in Fresenius Medical Care on September 5, 2024 and sell it today you would earn a total of  328.00  from holding Fresenius Medical Care or generate 16.36% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Smith Nephew SNATS  vs.  Fresenius Medical Care

 Performance 
       Timeline  
Smith Nephew SNATS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Smith Nephew SNATS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Fresenius Medical Care 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Fresenius Medical Care are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain primary indicators, Fresenius Medical unveiled solid returns over the last few months and may actually be approaching a breakup point.

Smith Nephew and Fresenius Medical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Smith Nephew and Fresenius Medical

The main advantage of trading using opposite Smith Nephew and Fresenius Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Smith Nephew position performs unexpectedly, Fresenius Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fresenius Medical will offset losses from the drop in Fresenius Medical's long position.
The idea behind Smith Nephew SNATS and Fresenius Medical Care pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Complementary Tools

Equity Valuation
Check real value of public entities based on technical and fundamental data
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Global Correlations
Find global opportunities by holding instruments from different markets